Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

EBENEZER KIO

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1164509535
CMS profile
188626
Location
GOSHEN, IN

General Payments · PY2018–2024

$40,195.24

  • Reported across 111 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$3,753.24

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $3,032.50 3
Travel and Lodging $378.57 3
Food and Beverage $342.17 7

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $1,800.00 1
Acerta Pharma LLC $1,650.44 6
Tempus AI, Inc $94.02 1
Adaptive Biotechnologies Corporation $90.38 1
Celgene Corporation $49.93 1
Aadi Bioscience, Inc. $37.08 2
Astellas Pharma US Inc $31.39 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $589.78 31
PY2019 $15,835.06 35
PY2020 $4,884.72 5
PY2021 $5,647.53 9
PY2022 $6,606.62 11
PY2023 $2,878.29 7
PY2024 $3,753.24 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Aadi Bioscience, Inc. $15.31 04/02/2024 Food and Beverage Undisputed 01/23/2026 1119596275 CMS
Aadi Bioscience, Inc. $21.77 04/16/2024 Food and Beverage Undisputed 01/23/2026 1119596277 CMS
ABBVIE INC. $1,800.00 12/19/2024 Consulting Fee Undisputed 01/23/2026 1103136261 CMS
Adaptive Biotechnologies Corporation $90.38 02/23/2024 Food and Beverage Undisputed 01/23/2026 1150261876 CMS
Astellas Pharma US Inc $31.39 05/14/2024 Food and Beverage Undisputed 01/23/2026 1139356641 CMS
AstraZeneca Pharmaceuticals LP $236.17 02/09/2024 Travel and Lodging Undisputed 01/23/2026 1104574478 CMS
AstraZeneca Pharmaceuticals LP $39.37 02/09/2024 Food and Beverage Undisputed 01/23/2026 1104669935 CMS
AstraZeneca Pharmaceuticals LP $132.40 02/09/2024 Travel and Lodging Undisputed 01/23/2026 1104721167 CMS
AstraZeneca Pharmaceuticals LP $400.00 02/19/2024 Consulting Fee Undisputed 01/23/2026 1105613527 CMS
AstraZeneca Pharmaceuticals LP $832.50 02/26/2024 Consulting Fee Undisputed 01/23/2026 1105794974 CMS
AstraZeneca Pharmaceuticals LP $10.00 04/01/2024 Travel and Lodging Undisputed 01/23/2026 1104603288 CMS
Celgene Corporation $49.93 02/24/2024 Food and Beverage Undisputed 01/23/2026 1101166994 CMS
Tempus AI, Inc $94.02 02/23/2024 Food and Beverage Undisputed 01/23/2026 1150167742 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.